A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT05668403 ·Status: RECRUITING ·Phase: PHASE1

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

NCT06522997 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

NCT07348237 ·Status: RECRUITING ·Phase: PHASE1

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05521191 ·Status: COMPLETED ·Phase: PHASE1

A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

NCT02110901 ·Status: COMPLETED ·Phase: PHASE3

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

NCT04235621 ·Status: TERMINATED

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

NCT03612856 ·Status: COMPLETED ·Phase: PHASE2

Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients

NCT03325621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases

NCT02639260 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial With KJ103 in Anti-GBM Disease

NCT06607016 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

NCT02522650 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

NCT05174221 ·Status: COMPLETED ·Phase: PHASE1

A Study in Participants With End-Stage Renal Disease

NCT01200290 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

NCT04492722 ·Status: TERMINATED ·Phase: PHASE2

The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.

NCT03466801 ·Status: TERMINATED ·Phase: NA

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

NCT03019653 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

NCT06496217 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

NCT07029139 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial

NCT05482698 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT02282930 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

NCT06470191 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease

NCT01843790 ·Status: COMPLETED ·Phase: PHASE2

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

NCT00120263 ·Status: COMPLETED ·Phase: NA